1. Home
  2. PGC vs SLS Comparison

PGC vs SLS Comparison

Compare PGC & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peapack-Gladstone Financial Corporation

PGC

Peapack-Gladstone Financial Corporation

HOLD

Current Price

$46.54

Market Cap

836.7M

Sector

Finance

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$11.30

Market Cap

924.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGC
SLS
Founded
1921
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
836.7M
924.5M
IPO Year
1997
2007

Fundamental Metrics

Financial Performance
Metric
PGC
SLS
Price
$46.54
$11.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$40.50
$10.00
AVG Volume (30 Days)
220.8K
10.5M
Earning Date
04-22-2026
05-11-2026
Dividend Yield
0.48%
N/A
EPS Growth
13.51
50.00
EPS
0.80
N/A
Revenue
$282,995,000.00
N/A
Revenue This Year
$32.39
N/A
Revenue Next Year
$12.64
$110.98
P/E Ratio
$57.10
N/A
Revenue Growth
24.05
N/A
52 Week Low
$24.45
$1.39
52 Week High
$49.14
$15.88

Technical Indicators

Market Signals
Indicator
PGC
SLS
Relative Strength Index (RSI) 53.61 47.46
Support Level $44.79 $3.91
Resistance Level $47.18 $15.88
Average True Range (ATR) 1.48 1.33
MACD -0.19 -0.38
Stochastic Oscillator 63.90 1.33

Price Performance

Historical Comparison
PGC
SLS

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: